Solasia Pharma K.K. (TYO:4597)
Japan flag Japan · Delayed Price · Currency is JPY
38.00
+1.00 (2.63%)
Jul 16, 2025, 9:42 AM JST

Solasia Pharma K.K. Revenue

Solasia Pharma K.K. had revenue of 25.00M JPY in the quarter ending March 31, 2025, with 127.27% growth. This brings the company's revenue in the last twelve months to 330.00M, down -19.12% year-over-year. In the year 2024, Solasia Pharma K.K. had annual revenue of 316.00M, down -48.78%.

Revenue (ttm)
330.00M
Revenue Growth
-19.12%
P/S Ratio
25.11
Revenue / Employee
14.35M
Employees
23
Market Cap
8.29B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 316.00M -301.00M -48.78%
Dec 31, 2023 617.00M -475.00M -43.50%
Dec 31, 2022 1.09B 533.00M 95.35%
Dec 31, 2021 559.00M 105.00M 23.13%
Dec 31, 2020 454.00M -856.00M -65.34%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,222.12B
Takeda Pharmaceutical Company 4,581.55B
Daiichi Sankyo Company 1,886.26B
HOYA Corporation 866.03B
Terumo 1,036.17B
Otsuka Holdings 2,393.18B
Astellas Pharma 1,912.32B
Shionogi & 438.27B
Revenue Rankings